+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market by Drug, Distribution Channel, and Region - Size, Share, Outlook, and Opportunity Analysis, 2022-2030

  • ID: 5589898
  • Report
  • April 2022
  • Region: Global
  • 177 Pages
  • Coherent Market Insights Pvt Ltd.

FEATURED COMPANIES

  • AbbVie Inc
  • Allay Therapeutics
  • Aurobindo Pharma
  • Delphis Pharmaceutical
  • GlaxoSmithKline plc
  • Johnson & Johnson
Many types of medicines are available to help control pain, including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), Acetaminophen, etc. Medications help people feel more comfortable, allowing one to start moving sooner, get the strength back more quickly, and recover from knee surgeries and arthroplasty faster.



Furthermore, increasing number of total knee arthroplasty is expected to drive the market growth over the forecast period
For instance, according to data published by National Center for Biotechnology Information in 2017, the number of total knee arthroplasty is estimated to range between 60,000 and 70,000 per year in Brazil.

Market Dynamics


Increasing research and development activities by the key players for the development and launch of knee surgeries and arthroplasty pain management drugs are expected to drive the growth of the global knee surgeries and arthroplasty pain management therapeutics market over the forecast period.

For instance, in May 2021, Allay Therapeutics, a clinical-stage biotechnology company, pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, announced the first-ever clinical data showing non-opioid pain relief lasting two weeks after a single administration. The existing post-surgical pain products have shown effectiveness for a maximum of three days after a single dose. The data come from a Phase 1b/2a clinical study of Allay’s first candidate, ATX-101, in development to treat pain after total knee arthroplasty (replacement) or TKA surgery.

Moreover, increasing approval of drug is also expected to boost the market growth. For instance, in march 2020, GlaxoSmithKline Plc. announced that the U.S. Food and Drug Administration had approved Advil Dual Action with Acetaminophen, as an (OTC) over-the-counter product for pain relief. Advil Dual Action gives relief for various symptoms and is the major formulation that merges acetaminophen and ibuprofen, 2 strong ingredients indicated for over-the-counter pain relief that work in different ways.

Key features of the study:

  • This report provides an in-depth analysis of the global knee surgeries and arthroplasty pain management therapeutics market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global knee surgeries and arthroplasty pain management therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer Inc, Allay Therapeutics, Mallinckrodt, Johnson & Johnson, Zydus Cadila Healthcare Ltd., Novartis AG, Purdue Pharma, Delphis Pharmaceutical, Taj Pharmaceuticals Limited, GlaxoSmithKline plc, AbbVie Inc., and Aurobindo Pharma
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global knee surgeries and arthroplasty pain management therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global knee surgeries and arthroplasty pain management therapeutics market

Detailed Segmentation


Global Knee Surgeries And Arthroplasty Pain Management Therapeutics Market, By Drug:

  • Acetaminophen
  • COX-2 inhibitors
  • Opioids
  • Non-steroidal Anti-inflammatories
  • Ketamine
  • Others

Global Knee Surgeries And Arthroplasty Pain Management Therapeutics Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Knee Surgeries And Arthroplasty Pain Management Therapeutics Market, By Region:

  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa

Company Profiles

  • Pfizer Inc*
  • Financial Overview
  • Market Strategies
  • Allay Therapeutics
  • Mallinckrodt
  • Johnson & Johnson
  • Zydus Cadila Healthcare Ltd.
  • Novartis AG
  • Purdue Pharma
  • Delphis Pharmaceutical
  • Taj Pharmaceuticals Limited
  • GlaxoSmithKline plc
  • AbbVie Inc
  • Aurobindo Pharma
“*” marked represents similar segmentation in other categories in the respective section.
Frequently Asked Questions about the Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market

What is the estimated value of the Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market?

The Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market was estimated to be valued at $4211.7 Million in 2022.

What is the growth rate of the Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market?

The growth rate of the Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market is 4.8%, with an estimated value of $6127.5 Million by 2030.

What is the forecasted size of the Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market?

The Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market is estimated to be worth $6127.5 Million by 2030.

Who are the key companies in the Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market?

Key companies in the Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market include Pfizer Inc, Allay Therapeutics, Mallinckrodt, Johnson & Johnson, Zydus Cadila Healthcare Ltd., Novartis AG, Purdue Pharma, Delphis Pharmaceutical and GlaxoSmithKline plc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc
  • Allay Therapeutics
  • Aurobindo Pharma
  • Delphis Pharmaceutical
  • GlaxoSmithKline plc
  • Johnson & Johnson

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Drug
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Opportunity Map
3. Market Dynamics, Regulations, and Trends Analysis
  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Number of Total Knee Arthroplasty Surgeries
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • Pipeline Analysis
  • Overview of Postoperative Pain Management Regimes for Total Knee Arthroplasty
4. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market – Impact of Coronavirus (Covid-19) Pandemic
  • COVID-19 Epidemiology
  • Overall Impact On Healthcare
  • Impact On Demand And Supply Analysis
5. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Drug, 2017 – 2030, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018–2030
  • Segment Trends
  • Acetaminophen
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
  • COX-2 inhibitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
  • Opioids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
  • Non-steroidal Anti-inflammatories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
  • Ketamine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
6. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Distribution Channel, 2017 – 2030, (US$ Mn)
  • Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018–2030
  • Segment Trends
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
7. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Region, 2017 – 2030, (US$ Mn)
  • Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018–2030
  • North America
  • Market Size and Forecast, By Drug, 2017 – 2030, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
  • Market Size and Forecast, By Drug, 2017 – 2030, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Market Size and Forecast, By Drug, 2017 – 2030, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Drug, 2017 – 2030, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Market Size and Forecast, By Drug, 2017 – 2030, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Market Size and Forecast, By Drug, 2017 – 2030, (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
  • Market Size and Forecast, By Region/Country, 2017 – 2030, (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa
8. Competitive Landscape
  • Competitive Snapshot
  • Pfizer Inc*
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Allay Therapeutics
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Mallinckrodt
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Johnson & Johnson
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Zydus Cadila Healthcare Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Novartis AG
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Purdue Pharma
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Delphis Pharmaceutical
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Taj Pharmaceuticals Limited
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • GlaxoSmithKline plc
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • AbbVie Inc
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Aurobindo Pharma
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
9. Section
  • References
  • Research Methodology
  • About the Analyst and Sales Contact
*Browse 27 market data tables and 30 figures on "Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market” - forecast to 2030
Note: Product cover images may vary from those shown
  • Pfizer Inc
  • Allay Therapeutics
  • Mallinckrodt
  • Johnson & Johnson
  • Zydus Cadila Healthcare Ltd.
  • Novartis AG
  • Purdue Pharma
  • Delphis Pharmaceutical
  • Taj Pharmaceuticals Limited
  • GlaxoSmithKline plc
  • AbbVie Inc
  • Aurobindo Pharma
Note: Product cover images may vary from those shown